Shanghai Microport Endovascular Medtec(Group) Co.,Ltd.’s Net Profit Rose 19.7% in First Three Quarters of 2022

Shanghai Microport Endovascular Medtec(Group) Co.,Ltd. (上海微创心脉医疗科技(集团)股份有限公司) (688016.SH) reported a net profit of 297.9 million yuan in the first three quarters of 2022, up 19.7% year-on-year.

Meanwhile, the company posted 664.2 million yuan in revenue, up 30.2% year-on-year.

At the end of the reporting period, it had 1.9 billion yuan in total assets and 206 million yuan in total liabilities, with a liability-to-asset ratio of 10.9%.